Academic Urology & Urogynecology of Arizona is a premier urology practice offering compassionate patient care to individuals throughout Arizona. Dr. Jeffrey A. Stern, Dr. Aaron LaTowsky, Dr. David Kaplan, Dr. Paul Papoff, Dr. Jennifer Klauschie, Dr. Chandan Kundavaram, Dr. John Mai, Dr. Amy Schlaifer, Dr. Joshua Jones, Dr. Keri Wong, Dr. Hemikaa Devakumar, and Dr. Debbie Sullivan offer state-of-the art treatment for urologic conditions, including prostate cancer, enlarged prostate, urinary incontinence, and vaginal prolapse.
Academic Urology & Urogynecology of Arizona has merged with Palo Verde Cancer Specialists.
Our Litchfield Park Clinic is now accepting appointments for every other Saturday of each month from 8:00am-2:00pm.
For more information or to schedule your appointment, visit the Make an Appointment page, or call us at 623.547.2600
The next revolution in prostate cancer surgery.
AUUA diagnoses a wide array of bladder conditions including overactive bladder and urinary retention.
A minimally invasive surgical technique for BPH.
Testing can help zero in on a fertility issue among a couple.
When detected early, it is one of the most treatable.
Prolapse can typically occur after child birth, menopause, or a hysterectomy.
Technological advances have made surgical vasectomy a low-risk and effective procedure.
Less invasive than traditional open kidney surgery.
This treatment is a minimally invasive, revolutionary approach to treating an enlarged prostate.
High-tech and minimally invasive, the da Vinci® Robotic Prostatectomy represents the next era of prostate cancer surgery. With the aid of physician-controlled robotic instrumentation and three-dimensional imagery imagery of the operating site...Read more
Academic Urology & Urogynecology of Arizona is a leader in clinical research. Patients benefit by having access to the most cutting-edge trials in prostate cancer, bladder cancer, enlarged prostate, erectile dysfunction, and urinary incontinence.
Osteoporosis May Be Present Before Prostate Cancer: ADT Danish study reveals a 10% prevalence of osteoporosis among men due to start androgen-deprivation therapy.
Listen to AUUA on
KPNX Channel 12 News: